Safety and Immunogenicity of Flublok Quadrivalent vs IIV4 in Adults 18-49 Years of Age
Clinical trial NCT02290509 · COMPLETED
Trial details
- NCT number
- NCT02290509
- Sponsor
- Protein Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-05-01
- Enrollment
- 1350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.